Investors & Partners

Strategic partnerships that drive our mission to bring innovative dermatology solutions to market.

Investors

Parent company and strategic investor providing resources and oversight for Celfex's development programs.

Clinical trial partner for Phase 2 development of topical Fexofenadine.

Scientific and research collaboration supporting early-stage development.

Development partner contributing formulation and translational expertise.

Clinical trial services and regulatory guidance partner.

Pharmaceutical partner supporting the Fexofenadine development program.

Commercial partner for European markets.

Clinical research partner supporting dermatology programs.

Strategic research collaboration for atopic dermatitis indications.

We are actively seeking strategic partners and investors to join us in advancing our dermatology pipeline.